NYU Grossman School of Medicine has been announced as a public health center of excellence as a part of the Centers for Disease Control and Prevention’s Alzheimer’s disease initiative.
The initiative, part of the Building Our Largest Dementia Infrastructure (BOLD) for Alzheimer’s Act, named three centers in the country to promote education, research, and communication to improve detection, prevention, and treatment of Alzheimer’s disease and related dementias.
“We want the public to know what is understood or not understood about this disease, and we want health providers to be ready to answer their patients’ questions and able to facilitate their needs,” says Joshua Chodosh, MD, director of The Michael L. Freedman Research Center on Aging, Technology, and Cognitive Health at NYU Langone Health.
NYU Grossman School of Medicine, located in Murray Hill, has been designated as the center focusing on the early detection of dementia. The Alzheimer’s Association in Chicago will focus on dementia risk reduction, and the University of Minnesota in Minneapolis will focus on dementia caregiving.
NYU Langone’s Division of Geriatric Medicine and Palliative Care will identify and develop early dementia detection strategies. The institute will work to share multimedia education materials with local, state, and tribal governments, healthcare providers, and the public, according to Dr. Chodosh.
Read more in Crain’s Health Pulse New York newsletter (subscription required).